Fuller & Thaler Asset Management Inc. Increases Position in Dolby Laboratories, Inc. (DLB)
Fuller & Thaler Asset Management Inc. lifted its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,338,058 shares of the electronics maker’s stock after purchasing an additional 2,292 shares during the quarter. Dolby Laboratories accounts for about 1.0% of Fuller & Thaler Asset Management Inc.’s portfolio, making the stock its 28th largest position. Fuller & Thaler Asset Management Inc.’s holdings in Dolby Laboratories were worth $82,960,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Eagle Boston Investment Management Inc. bought a new stake in shares of Dolby Laboratories during the 4th quarter valued at approximately $202,000. State of Alaska Department of Revenue bought a new stake in shares of Dolby Laboratories during the 4th quarter valued at approximately $198,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Dolby Laboratories by 48.9% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,472 shares of the electronics maker’s stock valued at $215,000 after purchasing an additional 1,141 shares during the last quarter. Berkshire Asset Management LLC PA bought a new stake in shares of Dolby Laboratories during the 3rd quarter valued at approximately $200,000. Finally, First Allied Advisory Services Inc. bought a new stake in shares of Dolby Laboratories during the 4th quarter valued at approximately $218,000. 53.79% of the stock is currently owned by institutional investors.
Shares of Dolby Laboratories, Inc. (NYSE DLB) opened at $61.86 on Friday. Dolby Laboratories, Inc. has a 1 year low of $48.00 and a 1 year high of $74.29. The company has a market cap of $6,451.62, a P/E ratio of 98.19, a P/E/G ratio of 5.25 and a beta of 0.78.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 14th. Investors of record on Monday, February 5th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, February 2nd. This represents a $0.64 annualized dividend and a yield of 1.03%. Dolby Laboratories’s dividend payout ratio is presently 101.59%.
In related news, Director Peter C. Gotcher sold 5,233 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $62.12, for a total transaction of $325,073.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 18,548 shares of Dolby Laboratories stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $61.40, for a total transaction of $1,138,847.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 649,085 shares of company stock worth $40,507,528. 43.80% of the stock is owned by corporate insiders.
DLB has been the topic of several research reports. Zacks Investment Research lowered shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 31st. B. Riley lowered shares of Dolby Laboratories to a “hold” rating and set a $63.00 price target on the stock. in a report on Thursday, January 25th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $62.00.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLB).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.